ExCellThera in the News
December 14, 2018
How ExCellThera is increasing the safety of allogeneic stem cell transplants ExCellThera Inc. is expanding cord blood into allogeneic stem cell transplants for cancer that have lower treatment-related mortality rates and GvHD incidence than competing technologies. Hematopoietic stem cell transplants (HSCTs) of unexpanded cord blood have two key drawbacks, according to CFO and Chief Legal Officer David Millette… BioCentury, December 14, 2019 (paywalled)
November 22, 2018
Dalton Pharma Services, a leading North American pharmaceutical cGMP CDMO, is pleased to announce its drug development and manufacturing services agreement with ExCellThera Inc, an innovative biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use. This agreement provides ExCellThera access to Dalton`s State-of-the-Art cGMP, Health Canada approved biopharmaceutical facility in Toronto, ON, Canada. Under the agreement terms… PRWeb, November 22, 2018
September 11, 2018
Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and hematologist at the Maisonneuve-Rosemont Hospital (CIUSSS de l’Est-de-l’Île-de-Montréal), has been elected a member of the Academy of Science of the Royal Society of Canada (RSC)… Markets Insider, September 11, 2018
June 27, 2018
Researchers behind a made-in-Canada technology for multiplying the number of stem cells that can be derived from donated cord blood say they are ready to move on to the next phase in their effort to prove the technology can save lives… The Globe and Mail, June 27, 2018
June 27, 2018
On connaît la multiplication des pains racontée dans les Évangiles. Mais voilà que des chercheurs québécois croient pouvoir sauver des vies grâce à un autre miracle : la multiplication des cellules souches dans le sang des cordons ombilicaux… La Presse, June 27, 2018
June 12, 2018
ExcellThera dévoilera sous peu les résultats de sa première étude clinique portant sur 25 patients atteints d’une forme de leucémie… La Presse, June 12, 2018
May 15, 2018
Umbilical cord blood, previously discarded, has been seen in more recent years as a useful source for blood stem cells. It contains haematopoietic stem cells that are usually… Biotechnology Focus, May 2018.
June 22, 2017
Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader. Mediaplanet, April, 2017.
November 4, 2016
A multitiered approach to stem cell discoveries. MaRS Magazine, November 4, 2016.
July 12, 2016
Returning to form: New funding gives hope for 10 new therapies over the next 10 years Bio Business, Sept./Oct. 2015.
January 5, 2016
In the Clinic: ExCellThera. BioWorld Today (page 12), December 22, 2015.
September 9, 2015
U of T Expands Research Facilities in New Partnership with MaRS. Faculty of Medicine, University of Toronto, September 2, 2015.
August 17, 2015
Banking on cord blood. Ontario Institute for Regenerative Medicine
July 1, 2015
Ten companies to watch. Stem Cell Assays, July 1, 2015.
June 22, 2015
Québec: ExCellThera veut transformer la greffe de cellules souches. BiotechFinances, June 22, 2015 [French only]